Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Dec 15, 2025
Reporting period
Not applicable
Filed with the SEC
Dec 16, 2025
CEOOption exercise
Context
Classification
option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001773751-25-000386
Filed / recorded
Dec 16, 2025, 9:31 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Hims & Hers Health, Inc.
Issuer CIK
1773751
Ticker
HIMS
Reporting person
Andrew Dudum
Relationship
Director, Officer, 10% owner
Officer title
Chief Executive Officer
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
Dec 15, 2025
Transaction code
M
Shares / units
35,242
Price per share
$0.00
Acquired / disposed
Disposed (D)
Shares owned after
35,242
Ownership form
Direct
Amendment
No
Footnotes from the filing
The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on each Company Quarterly Vesting Date occurring on or after June 15, 2022.